$103.42 0.00 (%) Gilead Sciences Inc - NASDAQ

Mar. 5, 2015 | 04:00 PM

Partner Headlines

  1. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  2. Making Money With Charles Payne: 02/27/15

    FoxBusiness | Feb. 27, 2015 | 18:00PM EST
  3. ImmunoVaccine Up 24% On Deal With Gilead Sciences

    Benzinga | Feb. 27, 2015 | 12:50PM EST
  4. UPDATE: Gilead Press Release Regarding Phase 3 Harvoni Study

    Benzinga | Feb. 26, 2015 | 15:15PM EST
  5. UPDATE: Gilead Reports Preclinical Data

    Benzinga | Feb. 25, 2015 | 15:29PM EST
  6. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  7. What Steven Cohen Is Doing With His Personal Wealth

    Benzinga | Feb. 18, 2015 | 15:42PM EST
  8. Tiger Management's Julian Robertson Buys Apple, Netflix, Illumina, Sells Alibaba, EBay, MasTec

    GuruFocus | Feb. 17, 2015 | 18:23PM EST
  9. Leon Cooperman's Omega Advisors Bought Gilead, Boosted Groupon & Liquidated Alibaba Last Quarter

    Benzinga | Feb. 17, 2015 | 15:55PM EST
  10. Biotech Performance 'Particularly Impressive,' Says JP Morgan

    Benzinga | Feb. 17, 2015 | 13:30PM EST
  11. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga | Feb. 17, 2015 | 12:17PM EST
  12. Gilead Sciences, Atlas Energy And Others Insiders Have Been Buying

    Benzinga | Feb. 14, 2015 | 19:46PM EST
  13. Netflix, Amazon Lead Q4 With Biggest Earnings Beat

    IBD | Feb. 13, 2015 | 16:41PM EST
  14. 8 Strong Recommendations for 2015

    GuruFocus | Feb. 13, 2015 | 15:36PM EST
  15. JMP Securities Covers Mostly Good News From Pharma Pending More Visibility

    Benzinga | Feb. 11, 2015 | 07:54AM EST
  16. Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial

    GuruFocus | Feb. 10, 2015 | 12:36PM EST
  17. Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown

    Benzinga | Feb. 9, 2015 | 11:46AM EST
  18. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margin

    Benzinga | Feb. 9, 2015 | 04:35AM EST
  19. Big Apple Fuels Earnings While Big Energy A Drag

    IBD | Feb. 6, 2015 | 19:04PM EST
  20. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's Viekira Pak

    GuruFocus | Feb. 6, 2015 | 10:59AM EST
  21. Credit Suisse Downgrades Gilead Sciences, Sees Declining HCV Revenues

    Benzinga | Feb. 6, 2015 | 09:34AM EST
  22. Benzinga's Top Downgrades

    Benzinga | Feb. 6, 2015 | 09:06AM EST
  23. Credit Suisse Downgrades Gilead Sciences To Neutral

    Benzinga | Feb. 6, 2015 | 07:53AM EST
  24. Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015

    GuruFocus | Feb. 5, 2015 | 11:35AM EST
  25. Merck hep C drug faces delays

    IBD | Feb. 4, 2015 | 19:29PM EST
  26. Gilead

    IBD | Feb. 4, 2015 | 19:28PM EST
  27. Stocks Fade In Late Trade; Hain Celestial Jumps

    IBD | Feb. 4, 2015 | 14:50PM EST
  28. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  29. Gilead Sciences Getting Crushed On Mixed Results

    Benzinga | Feb. 4, 2015 | 11:59AM EST
  30. AbbVie's Q4 Reflects Its Tremendous Growth Potential Going Forward

    GuruFocus | Feb. 4, 2015 | 11:58AM EST
  31. Stocks Turn Mixed; Airlines Cruise Up

    IBD | Feb. 4, 2015 | 11:52AM EST
  32. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus | Feb. 4, 2015 | 11:24AM EST
  33. Stocks, Volume Get Mixed Start; Sony, Manhattan, Noah Spike

    IBD | Feb. 4, 2015 | 10:43AM EST
  34. Morning Market Losers

    Benzinga | Feb. 4, 2015 | 09:54AM EST
  35. Wednesday Morning Movers: Gilead Sciences, Myriad Genetics Tumble Following Earnings

    Benzinga | Feb. 4, 2015 | 09:39AM EST
  36. Stock Futures Aim For Soft Open; Gilead, Chipotle Take Hard Hits

    IBD | Feb. 4, 2015 | 08:58AM EST
  37. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 4, 2015 | 08:16AM EST
  38. Gilead Q4 Earnings Beat, But Price War Taking Toll

    IBD | Feb. 3, 2015 | 19:26PM EST
  39. Gilead Beats Views, Pays Out

    IBD | Feb. 3, 2015 | 18:56PM EST
  40. Aetna outlook up on drug costs

    IBD | Feb. 3, 2015 | 18:35PM EST
  41. Looking Ahead of Wall Street: Gilead Sciences, Chipotle, Twitter

    GuruFocus | Feb. 3, 2015 | 18:27PM EST
  42. Nuveen's Bob Doll Runs Several Top Funds

    IBD | Feb. 3, 2015 | 18:22PM EST
  43. Top Performing Funds Favor Leisure, Medical, REITs

    IBD | Feb. 3, 2015 | 18:22PM EST
  44. Making Money With Charles Payne: 02/03/15

    FoxBusiness | Feb. 3, 2015 | 18:00PM EST
  45. Tuesday's After-Hours Movers: Gilead, Wynn Resorts And Chipotle Fall Following Earnings

    Benzinga | Feb. 3, 2015 | 17:53PM EST
  46. Gilead Sciences Beats Q4 Views But Outlook Disappoints, Shares Fall

    Benzinga | Feb. 3, 2015 | 17:45PM EST
  47. Stocks Close Strong With Energy Stocks Leading

    IBD | Feb. 3, 2015 | 17:04PM EST
  48. Gilead Sciences Q4 Conference Call: Live Blog

    Benzinga | Feb. 3, 2015 | 16:05PM EST
  49. Stocks On Pace For Second Straight Gain; Salix Rallies

    IBD | Feb. 3, 2015 | 14:59PM EST
  50. Gilead Sciences Earnings Preview: Hepatitis C Guidance Is Key

    Benzinga | Feb. 3, 2015 | 14:13PM EST
Trading Center